{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:16:38Z","timestamp":1790334998898,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD087198"],"award-info":[{"award-number":["HD087198"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The clinical outcome of allogeneic hematopoietic stem cell transplantation (SCT) may be influenced by the metabolic status of the recipient following conditioning, which in turn may enable risk stratification with respect to the development of transplant-associated complications such as graft vs. host disease (GVHD). To better understand the impact of the metabolic profile of transplant recipients on post-transplant alloreactivity, we investigated the metabolic signature of 14 patients undergoing myeloablative conditioning followed by either human leukocyte antigen (HLA)-matched related or unrelated donor SCT, or autologous SCT. Blood samples were taken following conditioning and prior to transplant on day 0 and the plasma was comprehensively characterized with respect to its lipidome and metabolome via liquid chromatography\/mass spectrometry (LCMS) and gas chromatography\/mass spectrometry (GCMS). A pro-inflammatory metabolic profile was observed in patients who eventually developed GVHD. Five potential pre-transplant biomarkers, 2-aminobutyric acid, 1-monopalmitin, diacylglycerols (DG 38:5, DG 38:6), and fatty acid FA 20:1 demonstrated high sensitivity and specificity towards predicting post-transplant GVHD. The resulting predictive model demonstrated an estimated predictive accuracy of risk stratification of 100%, with area under the curve of the ROC of 0.995. The likelihood ratio of 1-monopalmitin (infinity), DG 38:5 (6.0), and DG 38:6 (6.0) also demonstrated that a patient with a positive test result for these biomarkers following conditioning and prior to transplant will be at risk of developing GVHD. Collectively, the data suggest the possibility that pre-transplant metabolic signature may be used for risk stratification of SCT recipients with respect to development of alloreactivity.<\/jats:p>","DOI":"10.3390\/cancers11081051","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T08:45:39Z","timestamp":1564130739000},"page":"1051","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature"],"prefix":"10.3390","volume":"11","author":[{"suffix":"Jr.","given":"Daniel","family":"Contaifer","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy and Outcomes Sciences, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-6351","authenticated-orcid":false,"given":"Naren Gajenthra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-9971","authenticated-orcid":false,"given":"Ramesh","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Physics, College of Humanities and Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Physics, College of Humanities and Sciences, Virginia Commonwealth University, Richmond, VA 23284, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Toor","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"},{"name":"Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayanjan S.","family":"Wijesinghe","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Outcomes Sciences, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA"},{"name":"Institute for Structural Biology Drug Discovery and Development (ISB3D), VCU School of Pharmacy, Richmond, VA 23298, USA"},{"name":"Da Vinci Center, Virginia Commonwealth University, Richmond, VA 23284, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jones, N., Cronin, J.G., Dolton, G., Panetti, S., Schauenburg, A.J., Galloway, S.A.E., Sewell, A.K., Cole, D.K., Thornton, C., and Francis, N.J. (2017). Metabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation. Front. Immunol.","DOI":"10.3389\/fimmu.2017.01516"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24129","DOI":"10.1038\/srep24129","article-title":"Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions","volume":"6","author":"Cretenet","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12185-016-2145-5","article-title":"Harmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation","volume":"105","author":"Rovira","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1172\/JCI82587","article-title":"Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation","volume":"126","author":"Nguyen","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2017.10.028","article-title":"Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3\/GPR174","volume":"494","author":"Shinjo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bai, A., and Guo, Y. (2017). Acid sphingomyelinase mediates human CD4+ T-cell signaling: Potential roles in T-cell responses and diseases. Cell Death Dis., 8.","DOI":"10.1038\/cddis.2017.360"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood-2008-11-191148","article-title":"Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease","volume":"114","author":"Rotolo","year":"2009","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4049\/jimmunol.1601569","article-title":"Leukotriene C4 Potentiates IL-33\u2013Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation","volume":"199","author":"Lund","year":"2017","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/eji.201546152","article-title":"Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease","volume":"46","author":"Raha","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.molimm.2015.07.023","article-title":"Rethinking the paradigm: How comparative studies on fatty acid oxidation inform our understanding of T cell metabolism","volume":"68","author":"Chiaranunt","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2013-04-495515","article-title":"Effector T cells require fatty acid metabolism during murine graft-versus-host disease","volume":"122","author":"Byersdorfer","year":"2013","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","article-title":"Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton\u2019s Jelly and bone marrow sources","volume":"264","author":"Najar","year":"2010","journal-title":"Cell. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2009-03-213850","article-title":"Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming","volume":"114","author":"Highfill","year":"2009","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cei.12423","article-title":"Mesenchymal stem cells suppress CD8+T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-\u03b2","volume":"178","author":"Li","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.tp.0000255575.03795.df","article-title":"Sparing Effect by Montelukast Treatment for Chronic Graft Versus Host Disease: A Pilot Study","volume":"83","author":"Or","year":"2007","journal-title":"Transplantation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.tp.0000255603.47512.57","article-title":"Montelukast in Chronic Graft-Versus-Host Disease: A Breath of Fresh Air?","volume":"83","author":"Vogelsang","year":"2007","journal-title":"Transplantation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/mt.2015.131","article-title":"Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2","volume":"23","author":"Reading","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_18","first-page":"121","article-title":"Oral eicosapentaenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation","volume":"28","author":"Takatsuka","year":"2002","journal-title":"Drugs Under Exp. Clin. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703226","article-title":"Oral eicosapentaenoic acid for complications of bone marrow transplantation","volume":"28","author":"Takatsuka","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood.V118.21.653.653","article-title":"FT1050 (16-dimethyl Prostaglandin E2)-Enhanced Umbilical Cord Blood Accelerates Hematopoietic Engraftment After Reduced Intensity Conditioning and Double Umbilical Cord Blood Transplantation","volume":"118","author":"Cutler","year":"2011","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood.V126.23.1884.1884","article-title":"Ex Vivo Modulation of Donor Cells Results in Enhanced Survival and Reduced Gvhd Mortality","volume":"126","author":"Guerrettaz","year":"2015","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kumar, N.G., Contaifer, D., Baker, P.R., Ekroos, K., Jefferson, K.K., and Wijesinghe, D.S. (2018). Untargeted lipidomic analysis to broadly characterize the effects of pathogenic and non-pathogenic staphylococci on mammalian lipids. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206606"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1194\/jlr.P068833","article-title":"Unsupervised analysis of combined lipid and coagulation data reveal coagulopathy subtypes among dialysis patients","volume":"58","author":"Contaifer","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/SHK.0000000000001093","article-title":"Metabolomics and Precision Medicine in Trauma: The State of the Field","volume":"50","author":"Jayaraman","year":"2017","journal-title":"Shock Augusta Ga"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/wound.2014.0589","article-title":"The Lipid Portion of Activated Platelet-Rich Plasma Significantly Contributes to Its Wound Healing Properties","volume":"4","author":"Hoeferlin","year":"2015","journal-title":"Adv. Wound Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/wound.2012.0402","article-title":"Systems-Level Lipid Analysis Methodologies for Qualitative and Quantitative Investigation of Lipid Signaling Events During Wound Healing","volume":"2","author":"Wijesinghe","year":"2013","journal-title":"Adv. Wound Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: An introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metabolomics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.bbmt.2016.04.022","article-title":"The role of biomarkers in the diagnosis and risk stratification of Acute Graft vs. Host Disease (aGvHD): A systematic review","volume":"22","author":"Ali","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Stikvoort, A., Chen, Y., R\u00e5destad, E., T\u00f6rl\u00e9n, J., Lakshmikanth, T., Bj\u00f6rklund, A., Mikes, J., Achour, A., Gertow, J., and Sundberg, B. (2017). Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease. Front. Immunol.","DOI":"10.3389\/fimmu.2017.00717"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbmt.2008.10.027","article-title":"Plasma Biomarkers in Graft-versus-Host Disease: A New Era?","volume":"15","author":"Paczesny","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Contaifer, D., Buckley, L.F., Wohlford, G., Kumar, N.G., Morriss, J.M., Ranasinghe, A.D., Carbone, S., Canada, J.M., Trankle, C., and Abbate, A. (2019). Metabolic modulation predicts heart failure tests performance. PLoS ONE, 14.","DOI":"10.1101\/555417"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Alborghetti, M.R., Correa, M.E.P., Whangbo, J., Shi, X., Aricetti, J.A., Da Silva, A.A., Miranda, E.C.M., Sforca, M.L., Caldana, C., and Gerszten, R.E. (2019). Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease. Front. Oncol.","DOI":"10.3389\/fonc.2019.00141"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11306-015-0880-x","article-title":"The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation","volume":"12","author":"Reikvam","year":"2016","journal-title":"Metabolomics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1074\/jbc.M601876200","article-title":"Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption","volume":"281","author":"Soga","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"36749","DOI":"10.1038\/srep36749","article-title":"2-Aminobutyric acid modulates glutathione homeostasis in the myocardium","volume":"6","author":"Irino","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_36","first-page":"1080","article-title":"Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU [1,3-bis(chloroethyl)-1-nitrosourea]","volume":"89","author":"Frischer","year":"1977","journal-title":"J. Lab. Clin. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0006-291X(78)91053-7","article-title":"Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates","volume":"83","author":"Babson","year":"1978","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2017.03.019","article-title":"Glutathione Primes T Cell Metabolism for Inflammation","volume":"46","author":"Mak","year":"2017","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1039\/C8AN00148K","article-title":"Reconstituting donor T cells increase their biomass following hematopoietic stem cell transplantation","volume":"143","author":"Leslie","year":"2018","journal-title":"Analyst"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: From molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-2275(20)33401-5","article-title":"Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol","volume":"40","author":"Ntambi","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_44","first-page":"1","article-title":"Role of ROS and RNS Sources in Physiological and Pathological Conditions","volume":"2016","author":"Reed","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_45","first-page":"42","article-title":"Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2\/LPC and ATX\/LPA axes","volume":"1831","author":"Sevastou","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chiurchi\u00f9, V., Leuti, A., and Maccarrone, M. (2018). Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. Front. Immunol.","DOI":"10.3389\/fimmu.2018.00038"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pharmthera.2015.01.008","article-title":"Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs","volume":"150","author":"Murray","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Beloribi-Djefaflia, S., Vasseur, S., and Guillaumond, F. (2016). Lipid metabolic reprogramming in cancer cells. Oncogenesis, 5.","DOI":"10.1038\/oncsis.2015.49"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2006.04.003","article-title":"PKD at the crossroads of DAG and PKC signaling","volume":"27","author":"Wang","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/emboj\/cdg009","article-title":"Protein kinase D mediates a stress-induced NF-\u03baB activation and survival pathway","volume":"22","author":"Storz","year":"2003","journal-title":"EMBO J."},{"key":"ref_51","unstructured":"(2018, February 06). The Serine Hydrolase ABHD6 Is a Critical Regulator of the Metabolic Syndrome: Cell Reports. Available online: http:\/\/www.cell.com\/cell-reports\/fulltext\/S2211-1247(13)00507-X?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS221112471300507X%3Fshowall%3Dtrue."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17558","DOI":"10.1073\/pnas.1314017110","article-title":"Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6","volume":"110","author":"Alhouayek","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11033-008-9230-7","article-title":"An unannotated \u03b1\/\u03b2 hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines","volume":"36","author":"Li","year":"2009","journal-title":"Mol. Biol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nmeth.3992","article-title":"An in vivo multiplexed small-molecule screening platform","volume":"13","author":"Schulze","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/dom.13008","article-title":"Monoacylglycerol signalling and ABHD6 in health and disease","volume":"19","author":"Poursharifi","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Battistini","year":"2015","journal-title":"Immunology"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Cabral, G.A., and Griffin-Thomas, L. (2009). Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects. Expert Rev. Mol. Med., 11.","DOI":"10.1017\/S1462399409000957"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"87ps24","DOI":"10.1126\/scitranslmed.3001628","article-title":"Breaking Free of Sample Size Dogma to Perform Innovative Translational Research","volume":"3","author":"Bacchetti","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_59","first-page":"333","article-title":"Statistical Analysis and Modeling of Mass Spectrometry-Based Metabolomics Data","volume":"1198","author":"Xi","year":"2014","journal-title":"Breast Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/8\/1051\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:09:35Z","timestamp":1760188175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/8\/1051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["cancers11081051"],"URL":"https:\/\/doi.org\/10.3390\/cancers11081051","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/475244","asserted-by":"object"}]},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]}}}